182 related articles for article (PubMed ID: 32721511)
21. Mutations of c-kit gene in bilateral testicular germ cell tumours in Japan.
Sakuma Y; Matsukuma S; Yoshihara M; Sakurai S; Nishii M; Kishida T; Kubota Y; Nagashima Y; Inayama Y; Sasaki T; Nakamura Y; Miura T; Kameda Y; Tsuchiya E; Miyagi Y
Cancer Lett; 2008 Jan; 259(1):119-26. PubMed ID: 18006222
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of male seminomatous and nonseminomatous germ cell tumors and response to first-line chemotherapy from a tertiary cancer center in India.
Joshi A; Zanwar S; Shetty N; Patil V; Noronha V; Bakshi G; Prakash G; Menon S; Prabhash K
Indian J Cancer; 2016; 53(2):313-316. PubMed ID: 28071636
[TBL] [Abstract][Full Text] [Related]
23. Somatic mutations of KIT in familial testicular germ cell tumours.
Rapley EA; Hockley S; Warren W; Johnson L; Huddart R; Crockford G; Forman D; Leahy MG; Oliver DT; Tucker K; Friedlander M; Phillips KA; Hogg D; Jewett MA; Lohynska R; Daugaard G; Richard S; Heidenreich A; Geczi L; Bodrogi I; Olah E; Ormiston WJ; Daly PA; Looijenga LH; Guilford P; Aass N; Fosså SD; Heimdal K; Tjulandin SA; Liubchenko L; Stoll H; Weber W; Einhorn L; Weber BL; McMaster M; Greene MH; Bishop DT; Easton D; Stratton MR
Br J Cancer; 2004 Jun; 90(12):2397-401. PubMed ID: 15150569
[TBL] [Abstract][Full Text] [Related]
24. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.
Honecker F; Wermann H; Mayer F; Gillis AJ; Stoop H; van Gurp RJ; Oechsle K; Steyerberg E; Hartmann JT; Dinjens WN; Oosterhuis JW; Bokemeyer C; Looijenga LH
J Clin Oncol; 2009 May; 27(13):2129-36. PubMed ID: 19289622
[TBL] [Abstract][Full Text] [Related]
25. Integrated Molecular Characterization of Testicular Germ Cell Tumors.
Shen H; Shih J; Hollern DP; Wang L; Bowlby R; Tickoo SK; Thorsson V; Mungall AJ; Newton Y; Hegde AM; Armenia J; Sánchez-Vega F; Pluta J; Pyle LC; Mehra R; Reuter VE; Godoy G; Jones J; Shelley CS; Feldman DR; Vidal DO; Lessel D; Kulis T; Cárcano FM; Leraas KM; Lichtenberg TM; Brooks D; Cherniack AD; Cho J; Heiman DI; Kasaian K; Liu M; Noble MS; Xi L; Zhang H; Zhou W; ZenKlusen JC; Hutter CM; Felau I; Zhang J; Schultz N; Getz G; Meyerson M; Stuart JM; ; Akbani R; Wheeler DA; Laird PW; Nathanson KL; Cortessis VK; Hoadley KA
Cell Rep; 2018 Jun; 23(11):3392-3406. PubMed ID: 29898407
[TBL] [Abstract][Full Text] [Related]
26. CNS germinomas are characterized by global demethylation, chromosomal instability and mutational activation of the Kit-, Ras/Raf/Erk- and Akt-pathways.
Schulte SL; Waha A; Steiger B; Denkhaus D; Dörner E; Calaminus G; Leuschner I; Pietsch T
Oncotarget; 2016 Aug; 7(34):55026-55042. PubMed ID: 27391150
[TBL] [Abstract][Full Text] [Related]
27. A c-KIT codon 816 mutation, D816H, in the testicular germ cell tumor: case report of a Japanese patient with bilateral testicular seminomas.
Tate G; Suzuki T; Kishimoto K; Mitsuya T
Acta Med Okayama; 2005 Feb; 59(1):33-6. PubMed ID: 15902997
[TBL] [Abstract][Full Text] [Related]
28. Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas.
Fukushima S; Otsuka A; Suzuki T; Yanagisawa T; Mishima K; Mukasa A; Saito N; Kumabe T; Kanamori M; Tominaga T; Narita Y; Shibui S; Kato M; Shibata T; Matsutani M; Nishikawa R; Ichimura K;
Acta Neuropathol; 2014; 127(6):911-25. PubMed ID: 24452629
[TBL] [Abstract][Full Text] [Related]
29. [Observation policy for residual masses after chemotherapy for gonadal and extra-gonadal germ cell tumors].
Takizawa A; Miura T; Fujinami K; Osada Y
Hinyokika Kiyo; 2005 Apr; 51(4):247-51. PubMed ID: 15912783
[TBL] [Abstract][Full Text] [Related]
30. Novel somatic and germline mutations in intracranial germ cell tumours.
Wang L; Yamaguchi S; Burstein MD; Terashima K; Chang K; Ng HK; Nakamura H; He Z; Doddapaneni H; Lewis L; Wang M; Suzuki T; Nishikawa R; Natsume A; Terasaka S; Dauser R; Whitehead W; Adekunle A; Sun J; Qiao Y; Marth G; Muzny DM; Gibbs RA; Leal SM; Wheeler DA; Lau CC
Nature; 2014 Jul; 511(7508):241-5. PubMed ID: 24896186
[TBL] [Abstract][Full Text] [Related]
31. EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors.
Chen KS; Fustino NJ; Shukla AA; Stroup EK; Budhipramono A; Ateek C; Stuart SH; Yamaguchi K; Kapur P; Frazier AL; Lum L; Looijenga LHJ; Laetsch TW; Rakheja D; Amatruda JF
Mol Cancer Ther; 2018 May; 17(5):1079-1089. PubMed ID: 29483210
[TBL] [Abstract][Full Text] [Related]
32. Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults.
McIntyre A; Summersgill B; Grygalewicz B; Gillis AJ; Stoop J; van Gurp RJ; Dennis N; Fisher C; Huddart R; Cooper C; Clark J; Oosterhuis JW; Looijenga LH; Shipley J
Cancer Res; 2005 Sep; 65(18):8085-9. PubMed ID: 16166280
[TBL] [Abstract][Full Text] [Related]
33. Genomic characteristics revealed by targeted exon sequencing of testicular germ cell tumors in Japanese men.
Matsumoto T; Shiota M; Uchiumi T; Ueda S; Tsukahara S; Toshima T; Matsumoto S; Noda N; Eto M; Kang D
Int J Urol; 2021 Jan; 28(1):40-46. PubMed ID: 33047348
[TBL] [Abstract][Full Text] [Related]
34. KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors.
Nakai Y; Nonomura N; Oka D; Shiba M; Arai Y; Nakayama M; Inoue H; Nishimura K; Aozasa K; Mizutani Y; Miki T; Okuyama A
Biochem Biophys Res Commun; 2005 Nov; 337(1):289-96. PubMed ID: 16188233
[TBL] [Abstract][Full Text] [Related]
35. [Studies on nuclear DNA content in testicular germ cell tumors using flow cytometry].
Kashiwagi A
Hokkaido Igaku Zasshi; 1992 Nov; 67(6):801-14. PubMed ID: 1336479
[TBL] [Abstract][Full Text] [Related]
36. Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial.
Subbiah V; Meric-Bernstam F; Mills GB; Shaw KR; Bailey AM; Rao P; Ward JF; Pagliaro LC
J Hematol Oncol; 2014 Aug; 7():52. PubMed ID: 25085632
[TBL] [Abstract][Full Text] [Related]
37. KIT Suppresses BRAF
Neiswender JV; Kortum RL; Bourque C; Kasheta M; Zon LI; Morrison DK; Ceol CJ
Cancer Res; 2017 Nov; 77(21):5820-5830. PubMed ID: 28947418
[TBL] [Abstract][Full Text] [Related]
38. Detection of preferential NRAS mutations in human male germ cell tumors by the polymerase chain reaction.
Ganguly S; Murty VV; Samaniego F; Reuter VE; Bosl GJ; Chaganti RS
Genes Chromosomes Cancer; 1990 Jan; 1(3):228-32. PubMed ID: 1964583
[TBL] [Abstract][Full Text] [Related]
39. Targeted treatment approaches in refractory germ cell tumors.
Galvez-Carvajal L; Sanchez-Muñoz A; Ribelles N; Saez M; Baena J; Ruiz S; Ithurbisquy C; Alba E
Crit Rev Oncol Hematol; 2019 Nov; 143():130-138. PubMed ID: 31634730
[TBL] [Abstract][Full Text] [Related]
40. Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy.
Ichimura K; Fukushima S; Totoki Y; Matsushita Y; Otsuka A; Tomiyama A; Niwa T; Takami H; Nakamura T; Suzuki T; Fukuoka K; Yanagisawa T; Mishima K; Nakazato Y; Hosoda F; Narita Y; Shibui S; Yoshida A; Mukasa A; Saito N; Kumabe T; Kanamori M; Tominaga T; Kobayashi K; Shimizu S; Nagane M; Iuchi T; Mizoguchi M; Yoshimoto K; Tamura K; Maehara T; Sugiyama K; Nakada M; Sakai K; Kanemura Y; Nonaka M; Asai A; Yokogami K; Takeshima H; Kawahara N; Takayama T; Yao M; Kato M; Nakamura H; Hama N; Sakai R; Ushijima T; Matsutani M; Shibata T; Nishikawa R;
Acta Neuropathol; 2016 Jun; 131(6):889-901. PubMed ID: 26956871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
